Market News AIOpen the app

Joint Q3 2026 Earnings Call Transcript

ResultsRead the original at Benzinga
Neutral

Joint's profit and adjusted EBITDA rose, but system-wide sales fell and its 2026 forecast still calls for lower comparable sales. These results point in different directions.

JYNT · Joint

AI read · Neutral

The AI's read

Better patient retention and higher patient value could help the business. But fewer new patients and lower monthly spending are holding back sales, and the company still expects comparable sales to fall this year. Stronger profit and weaker sales point in different directions.

Get alerts for JYNT

Follow Joint (JYNT) free. When we publish a story about it, you get the plain-English explanation as an alert.

Get alerts for JYNT
Free on the App Store and Google Play, or on the web.